Skip to main content

Breadcrumb

  1. Home

Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study

Role of epigenetic regulators in Single Base Substitution patterns in AML

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Role of epigenetic regulators in Single Base Substitution patterns in AML

Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC)

ctDNA detection in early-stage non-small cell lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about ctDNA detection in early-stage non-small cell lung cancer

Clinical utility of TP53 mutations (TP53m) dynamic monitoring in circulating tumor DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Clinical utility of TP53 mutations (TP53m) dynamic monitoring in circulating tumor DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)

Impact of COVID-19 on Delay in Cancer Diagnostic Testing

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Impact of COVID-19 on Delay in Cancer Diagnostic Testing

Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer

Use of Receptor Occupancy Assays on Cells from Peripheral Blood As a Model to Determine Therapeutic Efficacy

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Use of Receptor Occupancy Assays on Cells from Peripheral Blood As a Model to Determine Therapeutic Efficacy

Detection of PAX5 Overexpression By RNA-Seq for B-Cell Lineage Detection in Acute Lymphocytic Leukemia

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:54
  • Read more about Detection of PAX5 Overexpression By RNA-Seq for B-Cell Lineage Detection in Acute Lymphocytic Leukemia

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • Page 65
  • …
  • Next page Next
  • Last page Last
Subscribe to